🏛️ Verified NIH Record • Updated 2026-05-15
Responses to Genetic Risk Modifier Testing Among Women With Pathogenic Variants in Breast Cancer Predisposition Genes (NCT03396341)
🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: Memorial Sloan Kettering Cancer Center
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to describe how women with BRCA1/2 mutations react to genetic risk modifier testing, and to examine how they make decisions about their healthcare.
Who can join: Review the eligibility criteria below.
Location: Dana Farber Cancer Institute (Data Collection Only) — Boston, Massachusetts
Age range: 25 Years
🧪 Interventions in This Study
- Salvia sample (OTHER)
- Questionnaires (BEHAVIORAL)
- Buccal swab sample (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (7 Sites)
- Dana Farber Cancer Institute (Data Collection Only) — Boston, Massachusetts
- Memorial Sloan-Kettering at Basking Ridge — Basking Ridge, New Jersey
- Memorial Sloan Kettering Commack — Commack, New York
- Memorial Sloan Kettering Westchester — Harrison, New York
- Memorial Sloan Kettering Cancer Center — New York, New York
- Memorial Sloan Kettering Nassau — Uniondale, New York
- Abramson Cancer Center at University of Pennsylvania Medical Center (Data Collection Only) — Philadelphia, Pennsylvania
📞 Contact the Study Coordinator
Phone: (646) 888-0049
Email: hamiltoj@mskcc.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Genetic Testing
- Prospective Registry of Multiplex Testing (PROMPT) — Boston, Massachusetts
- Universal Genetic Testing for Cancer Risk Reduction — New York, New York
- Video Education With Result Dependent dIsclosure — Boston, Massachusetts
Explore by condition: All Genetic Testing clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.